EULAR recommendations for the management of systemic lupus erythematosus: 2023 update.

The 2023 EULAR update for systemic lupus erythematosus sets 5 overarching principles and 13 recommendations, emphasizing hydroxychloroquine for all patients, minimizing glucocorticoids to 5 mg/day or less, and incorporating newer agents such as anifrolumab, belimumab, and voclosporin.